glutathione deficiency and neurological disorders Parkinson's Disease Treatment Diseases Linked to LOW GLUTATHIONE
Description
enhanced programmed cell death-1 expression on macrophage membranes and coated them onto rapamycin (RAPA)-loaded PLGA core to fabricate a novel nano-platform (PD-1-MM@PLGA/RAPA) (Fig

This degradation gives rise to trans-6-(4-hydroxy-3-methoxyphenyl)-2, 4-dioxo-5-hexanal, which then undergoes further cleavage to yield compounds like ferulic acid, feruloymethane, and vanillin (95)

Muellegger, R

Qian ZY, Peng Q, Zhang ZW, Zhou LA, Miao Y

In contrast, non-cleavable linkersdue to their high stability in blood and normal tissuescan significantly reduce free drug concentrations, thereby lowering off-target toxicity

Une posologie par voie orale de 4 000 g (durant les 2 premiers trimestres de la grossesse) et 5 000 g (durant le 3me trimestre et lallaitement) tous les 15 jours chez les femmes enceintes/allaitantes ayant un apport en vitamine B12 insuffisant
